z-logo
open-access-imgOpen Access
False-Negative Result for Cocaine Metabolites on a Lateral-Flow Drug Test Slide Corrected by Dilution
Author(s) -
Raffick A.R. Bowen,
David T. George,
Glen L. Hortin
Publication year - 2005
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2004.046607
Subject(s) - drug , dilution , chromatography , test (biology) , pharmacology , chemistry , medicine , biology , physics , paleontology , thermodynamics
Cocaine is one of the most widespread drugs of abuse; therefore, clinical laboratories are frequently requested to screen for the presence of cocaine and its metabolites in urine. When screening a urine specimen from a potential study participant for drugs of abuse, using a Verdict™ II lateral flow test slide (MEDTOX™ Diagnostics), multiple technologists obtained a negative screening result for benzoylecgonine (BE) on repeat analysis (n = 25). Because the study participant did not show symptoms of cocaine toxicity despite admitting to cocaine use and because the Verdict II drug test slide gave a negative result, the urine specimen was sent to Mayo Medical Laboratory (Rochester, MN) for a comprehensive drug screen and confirmation of cocaine and its metabolites by gas chromatography-mass spectrometry (Model 5973; Agilent™ Technologies) using solid-phase extraction and trimethylsilyl derivatization, as described by Chinn et al. (1). Gas chromatographic-mass spectrometric testing indicated that the urine …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom